Blog

  • Agbassio Brings the Complete Council of Seven to SILMO Paris
    Following its international debut at MIDO Milano, Agbassio will present its complete collection at SILMO Paris 2026. For the first time, all seven archetypes within the Council of Seven will be shown together across 96 individual SKUs, encompassing a full range of colors, finishes and lens variations. Created entirely in Japan, Agbassio is a prestige […]
  • How to handle co-management billing
    The role of modifiers in pre- and postoperative care billing. — Curated from external eye-care sources for opthametry.com readers. Read Full Article → 📰 Original Source: AOA News
  • Harrow acquires global rights to Tyrvaya
    Harrow has acquired the global rights to Tyrvaya from Viatris in a deal worth up to $100 million, according to a press release.Harrow will pay $30 million at closing, which is expected in the second half of the year. The agreement also includes payments of up to $70 million based on net sales, according to […]
  • FDA approves Lytenava for wet AMD
    The FDA approved Lytenava for the treatment of neovascular age-related macular degeneration, according to a press release from Outlook Therapeutics. The approval of Lytenava is marks the first and only FDA-approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the United States. Bevacizumab-vikg, a recombinant humanized IgG1 monoclonal antibody specific for human […]
  • Noninvasive bioelectric therapy for dry AMD begins pivotal study
    A pivotal trial is now underway for i-Lumen AMD, a bioelectric therapy being investigated for intermediate to advanced dry age-related macular degeneration, according to a press release from i-Lumen Scientific. The noninvasive, office-based therapy applies low-level microcurrent stimulation via the closed eyelid, which may improve photoreceptor cell function by repolarizing retinal pigment epithelium cells, according […]
  • Noninvasive bioelectric therapy for dry AMD begins pivotal study
    A pivotal trial is now underway for i-Lumen AMD, a bioelectric therapy being investigated for intermediate to advanced dry age-related macular degeneration, according to a press release from i-Lumen Scientific.The noninvasive, office-based therapy applies low-level microcurrent stimulation via the closed eyelid, which may improve photoreceptor cell function by repolarizing retinal pigment epithelium cells, according to […]
  • Robots will enhance surgery, not replace humans
    Click here to read the Healio Exclusive, “Embrace the future’ of robotics in ophthalmology.”I wrote an earlier perspective on the application of robotics to eye surgery in the April 25, 2024, issue of Healio | OSN.Since that time, significant progress has been made, including completion of the first in-human robot-assisted cataract surgery by two leading […]
  • Refractive surgery embraces era of corneal preservation
    While laser-based procedures continue to deliver excellent refractive outcomes in appropriate candidates, we now better understand the cumulative impact of laser ablation on corneal strength, nerve architecture and ocular surface health.Because of this expanding insight into corneal biomechanics, as well as access to effective lens-based procedures, corneal preservation plays an increasingly important role in how […]
  • ‘Embrace the future’ of robotics in ophthalmology
    Click here to read the At Issue to this Healio Exclusive.When new technology is developed, even one that seems revolutionary or inevitable, skepticism is normal.John A. Hovanesian, MD, FACS, remembers the initial rollout of self-driving cars and some of the disaster stories he saw in the early days after that technology became available to the […]
  • General public unaware of prevalence, impact of dry eye disease
    WASHINGTON — The general population may not be as educated about the prevalence of dry eye disease or its impact on vision as many ophthalmologists may believe, according to a speaker.At the American Society of Cataract and Refractive Surgery meeting, Francis S. Mah, MD, of Scripps Clinic Medical Group, and colleagues recruited 2,003 participants for […]
  • Study shows slower reading, fixation alterations in glaucoma
    Patients with glaucoma displayed impaired reading performance and increased saccades, according to a cross-sectional study published in Journal of Glaucoma.“The ability to read is essential for many aspects of daily living, including work-related activities, driving and shopping,” Mariana Chiba Ikeda, MD, of Federal University of São Paulo, and colleagues, wrote. ”… With the growing reliance […]
  • Additive keratoplasty provides noninvasive option for keratoconus
    KIAWAH ISLAND, S.C. — In this video from Kiawah Eye & Retina, Beeran B. Meghpara, MD, highlights the benefits of treating keratoconus with additive keratoplasty.“Whether that’s CTAK or CAIRS, we now have a fairly noninvasive surgical way, especially compared with corneal transplantation, to help patients improve their vision, whether it’s uncorrected visual acuity, spectacle corrected visual […]
  • Microperimetry helps track structure, function in GA
    LAS VEGAS — Customized microperimetry helped researchers track geographic atrophy in patients undergoing CTx001 gene therapy, according to a presentation at Clinical Trials at the Summit.Arshad Khanani, MD, MA, FASRS, of Sierra Eye Associates in Reno, Nevada, presented initial findings from the first cohort of patients enrolled in the phase 1/2 Opti-GAIN study. The primary […]
  • Dompé evaluating intranasal spray for NAION in phase 3 study
    The first patient has been enrolled in the phase 3 Galassia-NAION-301 study to evaluate an intranasal spray for the treatment of nonarteritic anterior ischemic optic neuropathy, according to a press release from Dompé.If approved, it would be the first FDA-approved treatment for nonarteritic anterior ischemic optic neuropathy (NAION), a spontaneous vision loss that can lead […]
  • All ophthalmologists should help address global visual impairment
    The WHO 2019 report on vision estimates that 36 million people in the world are blind and another 217 million have moderate to severe visual impairment.The International Agency for the Prevention of Blindness states that 1.1 billion of the world’s 8 billion people suffer from visual impairment.About 90% of people with vision impairment live in […]